Catalent, Inc.
CTLTDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596783
Catalent, Inc. was delisted in 2024; its insiders filed their last Form 4 on Dec 18, 2024; 472 institutions reported holding it in 13F filings for Q3 2024, worth $10.8B in total; Elliott Investment Management was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 472
- Q3 2024, +25 vs. previous quarter
- 13F value
- $10.8B
- Reported value at the end of Q3 2024
- Superinvestors holding
- 1
- At the end of Q3 2024
Superinvestors holding CTLT, Q3 2024
1 superinvestor reports holding Catalent, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Elliott Investment Management
Paul Singer
2.3%
Catalent, Inc.'s share of the portfolio
- Shares
- 4,000,000
- Value
- $242.3M
Latest insider trades
Open-market purchases and sales by Catalent, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2024 (view filing) | Nov 11 | 3 daysLate | Ryan Michelle RDirector | SSale | −2.80K | $59.70 | −$167.2K | −20.5%10.8K after | |
| Oct 21, 2024 (view filing) | Oct 18 | 3 days | Ferraro Joseph AnthonySVP, General Counsel, CCO | SSale | −320 | $59.97 | −$19.2K | −1.3%24.0K after | |
| Sep 27, 2024 (view filing) | Sep 26 | 1 day | McErlane DavidGroup President, Biologics | SSale | −1.99K | $59.97 | −$119.6K | −5.2%36.3K after | |
| Aug 5, 2024 (view filing) | Aug 2 | 3 days | Hopson RickyPres. BioProduct Delivery, CoS | SSale | −662 | $59.56 | −$39.4K | −2.2%30.0K after | |
| Aug 5, 2024 (view filing) | Aug 2 | 3 days | Gunther ScottSVP, Quality & Reg. Affairs | SSale | −666 | $59.55 | −$39.7K | −1.7%39.6K after | |
| Aug 5, 2024 (view filing) | Aug 2 | 3 days | Ferraro Joseph AnthonySVP, General Counsel, CCO | SSale | −608 | $59.58 | −$36.2K | −2.4%24.3K after | |
| Aug 5, 2024 (view filing) | Aug 2 | 3 days | Evoli LisaSVP, Chief HR Officer | SSale | −3.86K | $59.67 | −$230.3K | −8.9%39.4K after | |
| Aug 5, 2024 (view filing) | Aug 2 | 3 days | Gennadios AristipposGroup Pres. Pharma & Consumer | SSale | −1.17K | $59.55 | −$69.6K | −1.0%113.7K after | |
| Jul 30, 2024 (view filing) | Jul 29 | 1 day | Maselli AlessandroPresident & CEO | SSale | −9.09K | $58.76 | −$534.0K | −4.9%177.5K after | |
| Jul 30, 2024 (view filing) | Jul 29 | 1 day | Hopson RickyPres. BioProduct Delivery, CoS | SSale | −206 | $58.67 | −$12.1K | −0.7%30.6K after |
Top 10 13F holders, Q3 2024
The largest institutional positions in Catalent, Inc. at the end of Q3 2024; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 20,232,750 | $1.23B | 0.02% | −158,328−0.8% | Reduced |
| BlackRock, Inc. | 15,908,969 | $963.6M | 0.02% | +15,908,969 | New |
| Farallon Capital Management, L.L.C. | 8,394,000 | $508.4M | 2.79% | +794,000+10.4% | Added |
| State Street Corp | 7,451,135 | $451.3M | 0.02% | +113,095+1.5% | Added |
| Capital World Investors | 6,398,483 | $387.6M | 0.06% | +1,486,760+30.3% | Added |
| Norges Bank | 4,786,133 | $289.9M | 0.04% | +197,357+4.3% | Added |
| Millennium Management LLC | 4,517,953 | $273.7M | 0.24% | +437,989+10.7% | Added |
| Barclays PLC | 4,284,643 | $259.5M | 0.11% | −681,431−13.7% | Reduced |
| Geode Capital Management, LLC | 4,265,795 | $257.5M | 0.02% | −44,869−1.0% | Reduced |
| Elliott Investment Management L.P.SuperinvestorElliott Investment Management | 4,000,000 | $242.3M | 2.27% | 00.0% | Unchanged |